Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of fibrinolysis (GO:0051918) | 9.00716799 |
2 | regulation of fibrinolysis (GO:0051917) | 8.50802468 |
3 | regulation of protein activation cascade (GO:2000257) | 7.54175505 |
4 | protein carboxylation (GO:0018214) | 7.22913223 |
5 | peptidyl-glutamic acid carboxylation (GO:0017187) | 7.22913223 |
6 | L-phenylalanine catabolic process (GO:0006559) | 7.20322004 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.20322004 |
8 | regulation of complement activation (GO:0030449) | 7.17998410 |
9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.69526233 |
10 | L-phenylalanine metabolic process (GO:0006558) | 6.69526233 |
11 | complement activation, alternative pathway (GO:0006957) | 6.41155041 |
12 | blood coagulation, intrinsic pathway (GO:0007597) | 6.29343595 |
13 | very-low-density lipoprotein particle assembly (GO:0034379) | 6.28978654 |
14 | fibrinolysis (GO:0042730) | 5.82764002 |
15 | exogenous drug catabolic process (GO:0042738) | 5.81069352 |
16 | intestinal cholesterol absorption (GO:0030299) | 5.74364545 |
17 | negative regulation of cholesterol transport (GO:0032375) | 5.71877377 |
18 | negative regulation of sterol transport (GO:0032372) | 5.71877377 |
19 | regulation of plasminogen activation (GO:0010755) | 5.69977115 |
20 | plasma lipoprotein particle assembly (GO:0034377) | 5.65348357 |
21 | regulation of cholesterol esterification (GO:0010872) | 5.58210417 |
22 | cholesterol efflux (GO:0033344) | 5.56457496 |
23 | plasma lipoprotein particle remodeling (GO:0034369) | 5.50934005 |
24 | protein-lipid complex remodeling (GO:0034368) | 5.50934005 |
25 | macromolecular complex remodeling (GO:0034367) | 5.50934005 |
26 | drug catabolic process (GO:0042737) | 5.45125502 |
27 | epoxygenase P450 pathway (GO:0019373) | 5.44649886 |
28 | glyoxylate metabolic process (GO:0046487) | 5.35629935 |
29 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.32675638 |
30 | low-density lipoprotein particle remodeling (GO:0034374) | 5.24126813 |
31 | high-density lipoprotein particle remodeling (GO:0034375) | 5.16764042 |
32 | protein-lipid complex assembly (GO:0065005) | 5.13769504 |
33 | ethanol oxidation (GO:0006069) | 5.12741618 |
34 | regulation of apoptotic cell clearance (GO:2000425) | 5.02353009 |
35 | omega-hydroxylase P450 pathway (GO:0097267) | 4.81971472 |
36 | negative regulation of protein activation cascade (GO:2000258) | 4.79259377 |
37 | reverse cholesterol transport (GO:0043691) | 4.77312781 |
38 | urea metabolic process (GO:0019627) | 4.76834055 |
39 | aromatic amino acid family catabolic process (GO:0009074) | 4.75685354 |
40 | phospholipid efflux (GO:0033700) | 4.71012950 |
41 | plasma lipoprotein particle organization (GO:0071827) | 4.70176890 |
42 | negative regulation of hemostasis (GO:1900047) | 4.67148700 |
43 | negative regulation of blood coagulation (GO:0030195) | 4.67148700 |
44 | plasma lipoprotein particle clearance (GO:0034381) | 4.65631192 |
45 | cellular glucuronidation (GO:0052695) | 4.51886910 |
46 | protein-lipid complex subunit organization (GO:0071825) | 4.47810938 |
47 | protein activation cascade (GO:0072376) | 4.45853036 |
48 | positive regulation of hemostasis (GO:1900048) | 4.39299624 |
49 | positive regulation of blood coagulation (GO:0030194) | 4.39299624 |
50 | acylglycerol homeostasis (GO:0055090) | 4.31984114 |
51 | triglyceride homeostasis (GO:0070328) | 4.31984114 |
52 | acute-phase response (GO:0006953) | 4.30063627 |
53 | regulation of humoral immune response (GO:0002920) | 4.29881516 |
54 | nitrogen cycle metabolic process (GO:0071941) | 4.29552530 |
55 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.29365387 |
56 | glutamate metabolic process (GO:0006536) | 4.27437386 |
57 | negative regulation of coagulation (GO:0050819) | 4.26499140 |
58 | glucuronate metabolic process (GO:0019585) | 4.24379741 |
59 | uronic acid metabolic process (GO:0006063) | 4.24379741 |
60 | bile acid metabolic process (GO:0008206) | 4.23470577 |
61 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.18412413 |
62 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.18412413 |
63 | urea cycle (GO:0000050) | 4.16652890 |
64 | ethanol metabolic process (GO:0006067) | 4.14318742 |
65 | negative regulation of lipase activity (GO:0060192) | 4.11531481 |
66 | negative regulation of wound healing (GO:0061045) | 4.10527484 |
67 | serine family amino acid catabolic process (GO:0009071) | 4.09963891 |
68 | regulation of bile acid biosynthetic process (GO:0070857) | 4.06693259 |
69 | positive regulation of coagulation (GO:0050820) | 4.04259288 |
70 | bile acid biosynthetic process (GO:0006699) | 4.02831986 |
71 | complement activation, classical pathway (GO:0006958) | 3.99273690 |
72 | negative regulation of complement activation (GO:0045916) | 3.82539660 |
73 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.81341244 |
74 | drug metabolic process (GO:0017144) | 3.79644366 |
75 | imidazole-containing compound metabolic process (GO:0052803) | 3.79519350 |
76 | glycine metabolic process (GO:0006544) | 3.72792841 |
77 | complement activation (GO:0006956) | 3.71599921 |
78 | lipoprotein metabolic process (GO:0042157) | 3.69693523 |
79 | regulation of cholesterol homeostasis (GO:2000188) | 3.61828526 |
80 | tyrosine metabolic process (GO:0006570) | 3.60573284 |
81 | cholesterol homeostasis (GO:0042632) | 3.59620455 |
82 | bile acid and bile salt transport (GO:0015721) | 3.58806092 |
83 | proline metabolic process (GO:0006560) | 3.58159017 |
84 | sterol homeostasis (GO:0055092) | 3.54673041 |
85 | sterol transport (GO:0015918) | 3.50772188 |
86 | cholesterol transport (GO:0030301) | 3.50772188 |
87 | intestinal absorption (GO:0050892) | 3.50583201 |
88 | positive regulation of extracellular matrix organization (GO:1903055) | 3.46991828 |
89 | regulation of triglyceride catabolic process (GO:0010896) | 3.44242653 |
90 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.44041316 |
91 | response to mercury ion (GO:0046689) | 3.43970961 |
92 | amino-acid betaine metabolic process (GO:0006577) | 3.41795648 |
93 | phenylpropanoid metabolic process (GO:0009698) | 3.39811632 |
94 | cytolysis (GO:0019835) | 3.39479264 |
95 | oxidative demethylation (GO:0070989) | 3.39002784 |
96 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.33170332 |
97 | sodium-independent organic anion transport (GO:0043252) | 3.32603898 |
98 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.29932738 |
99 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.28641170 |
100 | alpha-amino acid catabolic process (GO:1901606) | 3.28337410 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.36527290 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.32011635 |
3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.28727463 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.82570451 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.33893103 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.01771253 |
7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.97511536 |
8 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 3.79424275 |
9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.73128400 |
10 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.91200120 |
11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.79597956 |
12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.75943359 |
13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.46496774 |
14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.23615040 |
15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.8336446 |
16 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.86981233 |
17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.80112092 |
18 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.69428817 |
19 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.68194272 |
20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50191260 |
21 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.45858413 |
22 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.42653536 |
23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.41991767 |
24 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.39422229 |
25 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.33023153 |
26 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.29799537 |
27 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.29465580 |
28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.28755607 |
29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.22129808 |
30 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.22017363 |
31 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.18313734 |
32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.12906425 |
33 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11929927 |
34 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09231200 |
35 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.07619857 |
36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.05510111 |
37 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02947823 |
38 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.01197918 |
39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00738134 |
40 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.00282037 |
41 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.99803338 |
42 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.99280185 |
43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97256010 |
44 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.96976433 |
45 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96620086 |
46 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.96039935 |
47 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.91852343 |
48 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.91807832 |
49 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91176842 |
50 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.89416171 |
51 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88856138 |
52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.88384106 |
53 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.87185140 |
54 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.87178066 |
55 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86216314 |
56 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.85897997 |
57 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.82606104 |
58 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.77333375 |
59 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.77059022 |
60 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.76570031 |
61 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76510403 |
62 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.76061476 |
63 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75686595 |
64 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.74987431 |
65 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.74546579 |
66 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.73673621 |
67 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.73619314 |
68 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.73495650 |
69 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.72899165 |
70 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.72820039 |
71 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.71604018 |
72 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.71377812 |
73 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.68729281 |
74 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.68454135 |
75 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.68174734 |
76 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.67448012 |
77 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.66948888 |
78 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.66927195 |
79 | TP53_16413492_ChIP-PET_HCT116_Human | 0.66492880 |
80 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.65763751 |
81 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.65138198 |
82 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.64116714 |
83 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.64055111 |
84 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.62931545 |
85 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.62392619 |
86 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.60688532 |
87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.60609205 |
88 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.60134382 |
89 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.59968090 |
90 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.58027143 |
91 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.57071210 |
92 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.57040562 |
93 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.56913538 |
94 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.56757506 |
95 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.52619493 |
96 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.52580338 |
97 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.51990074 |
98 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.51632231 |
99 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.50672689 |
100 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.50022300 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.74083578 |
2 | MP0005360_urolithiasis | 5.92697069 |
3 | MP0005365_abnormal_bile_salt | 5.79188328 |
4 | MP0005085_abnormal_gallbladder_physiolo | 5.26410857 |
5 | MP0003195_calcinosis | 5.19624972 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.59628988 |
7 | MP0001666_abnormal_nutrient_absorption | 3.84483082 |
8 | MP0010329_abnormal_lipoprotein_level | 3.63927568 |
9 | MP0003252_abnormal_bile_duct | 3.51270206 |
10 | MP0003868_abnormal_feces_composition | 3.21911914 |
11 | MP0003122_maternal_imprinting | 3.06758202 |
12 | MP0002138_abnormal_hepatobiliary_system | 2.33727037 |
13 | MP0009840_abnormal_foam_cell | 2.32404929 |
14 | MP0005332_abnormal_amino_acid | 2.12026890 |
15 | MP0000609_abnormal_liver_physiology | 1.87249088 |
16 | MP0002118_abnormal_lipid_homeostasis | 1.85239232 |
17 | MP0005408_hypopigmentation | 1.84844731 |
18 | MP0000566_synostosis | 1.84587560 |
19 | MP0003123_paternal_imprinting | 1.68650579 |
20 | MP0009697_abnormal_copulation | 1.67376883 |
21 | MP0003191_abnormal_cellular_cholesterol | 1.63072654 |
22 | MP0001915_intracranial_hemorrhage | 1.58775983 |
23 | MP0002876_abnormal_thyroid_physiology | 1.58122400 |
24 | MP0010368_abnormal_lymphatic_system | 1.49650713 |
25 | MP0002089_abnormal_postnatal_growth/wei | 1.49635990 |
26 | MP0003690_abnormal_glial_cell | 1.44479711 |
27 | MP0005058_abnormal_lysosome_morphology | 1.40200619 |
28 | MP0000604_amyloidosis | 1.37736946 |
29 | MP0005451_abnormal_body_composition | 1.35549018 |
30 | MP0000920_abnormal_myelination | 1.28469035 |
31 | MP0003172_abnormal_lysosome_physiology | 1.27638589 |
32 | MP0003329_amyloid_beta_deposits | 1.26919685 |
33 | MP0001661_extended_life_span | 1.22772816 |
34 | MP0003806_abnormal_nucleotide_metabolis | 1.20279889 |
35 | MP0004019_abnormal_vitamin_homeostasis | 1.19956616 |
36 | MP0001764_abnormal_homeostasis | 1.15943712 |
37 | MP0009780_abnormal_chondrocyte_physiolo | 1.15640587 |
38 | MP0002132_abnormal_respiratory_system | 1.13025300 |
39 | MP0003879_abnormal_hair_cell | 1.08631491 |
40 | MP0000598_abnormal_liver_morphology | 1.05294125 |
41 | MP0003656_abnormal_erythrocyte_physiolo | 0.96380872 |
42 | MP0005636_abnormal_mineral_homeostasis | 0.94117331 |
43 | MP0005409_darkened_coat_color | 0.92760140 |
44 | MP0003632_abnormal_nervous_system | 0.92019286 |
45 | MP0005319_abnormal_enzyme/_coenzyme | 0.90907998 |
46 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90687476 |
47 | MP0000639_abnormal_adrenal_gland | 0.85640748 |
48 | MP0005167_abnormal_blood-brain_barrier | 0.85064362 |
49 | MP0009642_abnormal_blood_homeostasis | 0.83590174 |
50 | MP0005464_abnormal_platelet_physiology | 0.81759810 |
51 | MP0009643_abnormal_urine_homeostasis | 0.81239262 |
52 | MP0004270_analgesia | 0.80855567 |
53 | MP0005670_abnormal_white_adipose | 0.78974353 |
54 | MP0002971_abnormal_brown_adipose | 0.78953140 |
55 | MP0003633_abnormal_nervous_system | 0.71383840 |
56 | MP0003631_nervous_system_phenotype | 0.71323446 |
57 | MP0003121_genomic_imprinting | 0.70936013 |
58 | MP0004272_abnormal_basement_membrane | 0.69699180 |
59 | MP0002078_abnormal_glucose_homeostasis | 0.65677935 |
60 | MP0005084_abnormal_gallbladder_morpholo | 0.59422194 |
61 | MP0003950_abnormal_plasma_membrane | 0.58157557 |
62 | MP0002909_abnormal_adrenal_gland | 0.55288369 |
63 | MP0006054_spinal_hemorrhage | 0.53533637 |
64 | MP0003075_altered_response_to | 0.53263173 |
65 | MP0005376_homeostasis/metabolism_phenot | 0.52461268 |
66 | MP0005023_abnormal_wound_healing | 0.51353372 |
67 | MP0003183_abnormal_peptide_metabolism | 0.50685556 |
68 | MP0008469_abnormal_protein_level | 0.50684634 |
69 | MP0009763_increased_sensitivity_to | 0.49122757 |
70 | MP0005448_abnormal_energy_balance | 0.49103730 |
71 | MP0005646_abnormal_pituitary_gland | 0.49092126 |
72 | MP0003011_delayed_dark_adaptation | 0.48658211 |
73 | MP0003638_abnormal_response/metabolism_ | 0.48076008 |
74 | MP0001756_abnormal_urination | 0.46986616 |
75 | MP0002064_seizures | 0.46245958 |
76 | MP0005395_other_phenotype | 0.45613863 |
77 | MP0002282_abnormal_trachea_morphology | 0.44484601 |
78 | MP0005164_abnormal_response_to | 0.44450577 |
79 | MP0003953_abnormal_hormone_level | 0.44209020 |
80 | MP0005220_abnormal_exocrine_pancreas | 0.43393364 |
81 | MP0002168_other_aberrant_phenotype | 0.42713295 |
82 | MP0005551_abnormal_eye_electrophysiolog | 0.42505376 |
83 | MP0005187_abnormal_penis_morphology | 0.39283282 |
84 | MP0009115_abnormal_fat_cell | 0.38987149 |
85 | MP0005377_hearing/vestibular/ear_phenot | 0.38863699 |
86 | MP0003878_abnormal_ear_physiology | 0.38863699 |
87 | MP0004883_abnormal_blood_vessel | 0.37972909 |
88 | MP0001270_distended_abdomen | 0.37963956 |
89 | MP0005257_abnormal_intraocular_pressure | 0.37906527 |
90 | MP0002933_joint_inflammation | 0.37213620 |
91 | MP0003115_abnormal_respiratory_system | 0.36810557 |
92 | MP0005410_abnormal_fertilization | 0.35756258 |
93 | MP0000003_abnormal_adipose_tissue | 0.34853474 |
94 | MP0005334_abnormal_fat_pad | 0.32888589 |
95 | MP0008569_lethality_at_weaning | 0.32553916 |
96 | MP0002229_neurodegeneration | 0.32330034 |
97 | MP0002249_abnormal_larynx_morphology | 0.32021453 |
98 | MP0003634_abnormal_glial_cell | 0.31274996 |
99 | MP0003566_abnormal_cell_adhesion | 0.30212650 |
100 | MP0003567_abnormal_fetal_cardiomyocyte | 0.29742323 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Prolonged partial thromboplastin time (HP:0003645) | 8.73285312 |
2 | Complement deficiency (HP:0004431) | 7.72153029 |
3 | Hypobetalipoproteinemia (HP:0003563) | 7.55307269 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 7.05878444 |
5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.79091437 |
6 | Joint hemorrhage (HP:0005261) | 6.74181524 |
7 | Abnormality of complement system (HP:0005339) | 5.99131598 |
8 | Abnormality of the common coagulation pathway (HP:0010990) | 5.55090997 |
9 | Systemic lupus erythematosus (HP:0002725) | 5.12413186 |
10 | Xanthomatosis (HP:0000991) | 5.03726363 |
11 | Glomerulonephritis (HP:0000099) | 5.00946229 |
12 | Conjugated hyperbilirubinemia (HP:0002908) | 4.77283631 |
13 | Hypolipoproteinemia (HP:0010981) | 4.57813301 |
14 | Spontaneous abortion (HP:0005268) | 4.46514678 |
15 | Hypercholesterolemia (HP:0003124) | 4.18094611 |
16 | Intrahepatic cholestasis (HP:0001406) | 4.06988880 |
17 | Hyperlipoproteinemia (HP:0010980) | 3.85459219 |
18 | Hemorrhage of the eye (HP:0011885) | 3.72859501 |
19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.67766805 |
20 | Epidermoid cyst (HP:0200040) | 3.41720455 |
21 | Menorrhagia (HP:0000132) | 3.38355061 |
22 | Vascular calcification (HP:0004934) | 3.34111070 |
23 | Fat malabsorption (HP:0002630) | 3.29756992 |
24 | Abnormality of the intrinsic pathway (HP:0010989) | 3.20027234 |
25 | Gingival bleeding (HP:0000225) | 3.18921283 |
26 | Mitral stenosis (HP:0001718) | 3.15008899 |
27 | Nephritis (HP:0000123) | 3.06711887 |
28 | Purpura (HP:0000979) | 2.98477370 |
29 | Acanthocytosis (HP:0001927) | 2.97498183 |
30 | Cardiovascular calcification (HP:0011915) | 2.93702195 |
31 | Hypoalphalipoproteinemia (HP:0003233) | 2.88710074 |
32 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.80585778 |
33 | Osteomalacia (HP:0002749) | 2.72537736 |
34 | Rickets (HP:0002748) | 2.70696232 |
35 | Hyperglycinemia (HP:0002154) | 2.60262838 |
36 | Thrombophlebitis (HP:0004418) | 2.57756098 |
37 | Arthropathy (HP:0003040) | 2.56660318 |
38 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.53693265 |
39 | Abnormality of carpal bone ossification (HP:0006257) | 2.53631414 |
40 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.51052322 |
41 | Myocardial infarction (HP:0001658) | 2.45916842 |
42 | Hypophosphatemic rickets (HP:0004912) | 2.44269996 |
43 | Abnormal tarsal ossification (HP:0008369) | 2.44112673 |
44 | Hepatocellular carcinoma (HP:0001402) | 2.37221552 |
45 | Generalized aminoaciduria (HP:0002909) | 2.27862818 |
46 | Hyperammonemia (HP:0001987) | 2.25686239 |
47 | Abnormality of glycine metabolism (HP:0010895) | 2.25198429 |
48 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.25198429 |
49 | Skin nodule (HP:0200036) | 2.23787987 |
50 | Pulmonary embolism (HP:0002204) | 2.19473096 |
51 | Abnormality of the Achilles tendon (HP:0005109) | 2.17939546 |
52 | Steatorrhea (HP:0002570) | 2.15200533 |
53 | Broad alveolar ridges (HP:0000187) | 2.13053778 |
54 | Increased serum pyruvate (HP:0003542) | 2.11446704 |
55 | Hyperglycinuria (HP:0003108) | 2.11160744 |
56 | Poikilocytosis (HP:0004447) | 2.10273318 |
57 | Scanning speech (HP:0002168) | 2.07804913 |
58 | Hypoglycemic coma (HP:0001325) | 2.06398593 |
59 | Small epiphyses (HP:0010585) | 2.05256955 |
60 | Abnormality of methionine metabolism (HP:0010901) | 2.04025332 |
61 | Bifid scrotum (HP:0000048) | 2.03964514 |
62 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.00613941 |
63 | Flat acetabular roof (HP:0003180) | 2.00486647 |
64 | Deep venous thrombosis (HP:0002625) | 11.3656747 |
65 | Abnormality of glycolysis (HP:0004366) | 1.96828081 |
66 | Enlarged kidneys (HP:0000105) | 1.92533064 |
67 | Alacrima (HP:0000522) | 1.92345340 |
68 | Abnormal gallbladder physiology (HP:0012438) | 1.92230494 |
69 | Cholecystitis (HP:0001082) | 1.92230494 |
70 | Delayed CNS myelination (HP:0002188) | 1.89426930 |
71 | Hepatoblastoma (HP:0002884) | 1.87738572 |
72 | Abnormality of the lumbar spine (HP:0100712) | 1.86914014 |
73 | Abnormal hand bone ossification (HP:0010660) | 1.85299982 |
74 | Abnormal ossification of hand bones (HP:0005921) | 1.83048181 |
75 | Facial shape deformation (HP:0011334) | 1.81576317 |
76 | Potter facies (HP:0002009) | 1.81576317 |
77 | Amyloidosis (HP:0011034) | 1.80552389 |
78 | Hydroxyprolinuria (HP:0003080) | 1.74603853 |
79 | Abnormality of proline metabolism (HP:0010907) | 1.74603853 |
80 | Retinal atrophy (HP:0001105) | 1.66479385 |
81 | Submucous cleft hard palate (HP:0000176) | 1.66018110 |
82 | Vaginal fistula (HP:0004320) | 1.64615125 |
83 | Broad palm (HP:0001169) | 1.64465707 |
84 | Fair hair (HP:0002286) | 1.64011172 |
85 | Joint swelling (HP:0001386) | 1.62199778 |
86 | Abnormal delivery (HP:0001787) | 1.61113798 |
87 | Epistaxis (HP:0000421) | 1.58515146 |
88 | Epiphyseal dysplasia (HP:0002656) | 1.58105969 |
89 | Hyperbilirubinemia (HP:0002904) | 1.58023396 |
90 | Abnormality of nucleobase metabolism (HP:0010932) | 1.57319952 |
91 | Abnormality of serum amino acid levels (HP:0003112) | 1.57318802 |
92 | Abnormality of pain sensation (HP:0010832) | 1.57038399 |
93 | Impaired pain sensation (HP:0007328) | 1.57038399 |
94 | Abnormality of the nasal septum (HP:0000419) | 1.56987639 |
95 | Back pain (HP:0003418) | 1.54370245 |
96 | Cholelithiasis (HP:0001081) | 1.51900667 |
97 | Hyperphosphaturia (HP:0003109) | 1.51482646 |
98 | Reduced antithrombin III activity (HP:0001976) | 1.44321925 |
99 | Mucopolysacchariduria (HP:0008155) | 1.43750194 |
100 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.43750194 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FGFR4 | 6.82780331 |
2 | FGFR3 | 4.53490107 |
3 | ICK | 3.34918194 |
4 | RIPK1 | 2.98993179 |
5 | FGFR2 | 2.71952957 |
6 | TYRO3 | 2.69298481 |
7 | WNK4 | 2.62979616 |
8 | CDK12 | 2.37091924 |
9 | ERN1 | 2.35338164 |
10 | NTRK3 | 2.31199282 |
11 | EPHA4 | 2.25652147 |
12 | PIK3CA | 2.12377241 |
13 | TRIB3 | 2.06887805 |
14 | PDGFRA | 1.93353106 |
15 | FGFR1 | 1.86953509 |
16 | WNK1 | 1.62680462 |
17 | RET | 1.49953282 |
18 | SGK223 | 1.48585866 |
19 | SGK494 | 1.48585866 |
20 | MAPK11 | 1.45082335 |
21 | PDPK1 | 1.44143347 |
22 | MAP3K2 | 1.37060455 |
23 | SIK2 | 1.33580674 |
24 | AKT3 | 1.33277004 |
25 | PRKAA2 | 1.29953279 |
26 | NTRK2 | 1.25461276 |
27 | SIK1 | 1.23917507 |
28 | DYRK1B | 1.21880096 |
29 | KSR2 | 1.17510187 |
30 | LATS2 | 1.15768833 |
31 | UHMK1 | 1.13624643 |
32 | PKN2 | 1.12813677 |
33 | PDK1 | 1.12370289 |
34 | ERBB2 | 1.09917436 |
35 | SGK3 | 1.04150903 |
36 | LATS1 | 1.01863423 |
37 | SGK1 | 0.96177063 |
38 | SGK2 | 0.93092409 |
39 | PRKACG | 0.92845753 |
40 | PRKCG | 0.87526839 |
41 | MAP3K9 | 0.86685833 |
42 | EEF2K | 0.86465078 |
43 | DDR2 | 0.85506623 |
44 | EIF2AK1 | 0.85127368 |
45 | TGFBR2 | 0.80604022 |
46 | IRAK3 | 0.79338091 |
47 | TYK2 | 0.74615906 |
48 | NEK9 | 0.73926920 |
49 | CSNK1E | 0.73675856 |
50 | RPS6KB1 | 0.71429839 |
51 | STK39 | 0.71181206 |
52 | PRKAA1 | 0.69878665 |
53 | NTRK1 | 0.69302643 |
54 | PRKCZ | 0.68765979 |
55 | BRSK1 | 0.65666736 |
56 | MAP2K4 | 0.65306558 |
57 | CAMKK1 | 0.65163113 |
58 | MAP3K1 | 0.64561246 |
59 | DAPK2 | 0.64298782 |
60 | MINK1 | 0.61709595 |
61 | CAMK1D | 0.58549385 |
62 | RPS6KA3 | 0.58093619 |
63 | CSNK1D | 0.56579105 |
64 | FGR | 0.56190578 |
65 | ALK | 0.55233305 |
66 | PRKG1 | 0.53111608 |
67 | MAPK10 | 0.51299414 |
68 | SRC | 0.51164554 |
69 | IGF1R | 0.50289729 |
70 | MARK1 | 0.49085219 |
71 | MAPKAPK3 | 0.46576212 |
72 | MAP3K3 | 0.45588865 |
73 | SCYL2 | 0.44883776 |
74 | MAP3K11 | 0.43475931 |
75 | MTOR | 0.43345109 |
76 | MET | 0.43143827 |
77 | CDK6 | 0.41479587 |
78 | STK38 | 0.41202836 |
79 | CDK5 | 0.41128970 |
80 | CDC42BPA | 0.40571072 |
81 | CDK7 | 0.39447226 |
82 | MAPKAPK5 | 0.38770730 |
83 | MAP3K5 | 0.38452025 |
84 | NEK6 | 0.38340760 |
85 | MAP3K7 | 0.37719855 |
86 | MARK2 | 0.37602983 |
87 | CDK15 | 0.37459985 |
88 | PTK6 | 0.36287392 |
89 | CAMK4 | 0.35658330 |
90 | JAK1 | 0.35355559 |
91 | PRKCB | 0.35010988 |
92 | PRPF4B | 0.34441926 |
93 | JAK2 | 0.34400924 |
94 | BCR | 0.34254714 |
95 | PTK2 | 0.33409129 |
96 | EPHA3 | 0.32965725 |
97 | CAMKK2 | 0.32835396 |
98 | SMG1 | 0.32634747 |
99 | CSF1R | 0.32516110 |
100 | FYN | 0.31518034 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.71962740 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.34943920 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31911631 |
4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.31381421 |
5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.91071690 |
6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.77822845 |
7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.70779324 |
8 | Retinol metabolism_Homo sapiens_hsa00830 | 2.68674010 |
9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.55969912 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48884920 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.47448168 |
12 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.37110108 |
13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.34697673 |
14 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.34276901 |
15 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.33474496 |
16 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.22938807 |
17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.11265021 |
18 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.03154088 |
19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.99478543 |
20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.98543464 |
21 | Bile secretion_Homo sapiens_hsa04976 | 1.95919873 |
22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.86545470 |
23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77757573 |
24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.72543179 |
25 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.63801658 |
26 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.63034815 |
27 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.61144035 |
28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.60185068 |
29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.59358902 |
30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.50540429 |
31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.46674627 |
32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.38987854 |
33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38750139 |
34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.32124081 |
35 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.30902016 |
36 | Peroxisome_Homo sapiens_hsa04146 | 1.25240451 |
37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.22984946 |
38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.20379056 |
39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17998833 |
40 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17179632 |
41 | ABC transporters_Homo sapiens_hsa02010 | 1.13598828 |
42 | Prion diseases_Homo sapiens_hsa05020 | 1.11733911 |
43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.99498992 |
44 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98741729 |
45 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.98224925 |
46 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.97793234 |
47 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.97124608 |
48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.93166306 |
49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.91765256 |
50 | Carbon metabolism_Homo sapiens_hsa01200 | 0.90860328 |
51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.88463089 |
52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.84672381 |
53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.82744083 |
54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.80982515 |
55 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.79606383 |
56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78790418 |
57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.70170942 |
58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.67858699 |
59 | Lysine degradation_Homo sapiens_hsa00310 | 0.64395308 |
60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.59547666 |
61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59446529 |
62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.48993180 |
63 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45671927 |
64 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.41278420 |
65 | Pertussis_Homo sapiens_hsa05133 | 0.38389811 |
66 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.37537144 |
67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36876751 |
68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31995534 |
69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.31001716 |
70 | Insulin resistance_Homo sapiens_hsa04931 | 0.30038755 |
71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29482205 |
72 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.29177639 |
73 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.29045396 |
74 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.23774961 |
75 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.19515830 |
76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19465225 |
77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.15602646 |
78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.14488893 |
79 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.14403309 |
80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.11844475 |
81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.09953690 |
82 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.09216369 |
83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.08031887 |
84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.07818012 |
85 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.05343466 |
86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.04658484 |
87 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.01456546 |
88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.00125599 |
89 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1317748 |
90 | Selenocompound metabolism_Homo sapiens_hsa00450 | -0.1273148 |
91 | Amoebiasis_Homo sapiens_hsa05146 | -0.1233088 |
92 | Long-term potentiation_Homo sapiens_hsa04720 | -0.1148739 |
93 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0952851 |
94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | -0.0900552 |
95 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0755208 |
96 | GABAergic synapse_Homo sapiens_hsa04727 | -0.0749352 |
97 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0620105 |
98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0590738 |
99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0475323 |
100 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0335832 |